Vitamin D/Calcium Polyp Prevention Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

2,813

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

October 31, 2013

Study Completion Date

June 30, 2016

Conditions
Colorectal CancerPolypsAdenomas
Interventions
DRUG

Calcium Carbonate

3 gm/daily; 1200 mg elemental calcium/daily; two tablets per day; 600 mg elemental calcium/tablet

DRUG

Vitamin D3

1000 IU/daily; two tablets per day; 500 IU per tablet

DRUG

placebo

placebo; two tablets per day

Trial Locations (11)

27599

University of North Carolina, Chapel Hill

29203

University of South Carolina, Columbia

30322

Emory University, Atlanta

44195

Cleveland Clinic Foundation, Cleveland

52242

University of Iowa, Iowa City

55455

University of Minnesota, Minneapolis

77030

University of Texas, Houston

80220

University of Colorado, Denver

90089

University of Southern California, Los Angeles

03766

Dartmouth Hitchcock Medical Center, Lebanon

Unknown

University of Puerto Rico, San Juan

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00153816 - Vitamin D/Calcium Polyp Prevention Study | Biotech Hunter | Biotech Hunter